In contrast, we have demonstrated that the selective inhibition of HDAC11 promoted the deacetylation of IRF4 — a vital signal pathway essential to the biology and oncogenic mechanism of plasma cell myeloma — and may provide a more effective translational strategy. The gene discussed is HDAC11; the disease is plasma cell myeloma.